Yale BioHaven Entrepreneurship Seminars Presents Vascular Insights:"Simplified Treatment For Varicose Veins"

Main Category: Vascular
Also Included In: Blood / Hematology;  Conferences
Article Date: 05 Nov 2007 - 3:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

The Yale BioHaven Entrepreneurship Seminars continues its fall schedule with a program on Vascular Insights, LLC on Tuesday November 13 from 4 to 5 p.m. in the Anlyan Center Auditorium, Yale School of Medicine, 300 Cedar Street. The series organized by the Yale Office of Cooperative Research and Connecticut United for Research Excellence (CURE).

Vascular Insights, LLC is a New Haven area start-up company founded to develop, manufacture and market the ClariVein-VA vascular ablation devices to treat varicose vein disease. The system they are developing combines technology licensed from Yale and its own intellectual property in a simplified procedure that uses a single, disposable product for elimination of varicose veins.

According to the founders of Vascular Insights, the company's procedure will eliminate the need for anesthesia, hospitalization or surgery, and will cause less damage to surrounding tissue and nerves than current therapies. They say this would translate into considerably reduced convalescence, complications and pain for patients.

The featured speakers will be co-founders John Marano, president and CEO of Vascular Insights; and Michael Tal, M.D., chief medical advisor of Vascular Insights and associate professor of radiology at Yale University School of Medicine.

Varicose vein disease affects an estimated 75 to 150 million people in North America and Western Europe, and that it is one of the least treated chronic conditions in the developed world.

"The market for treatment of varicose vein disease is just waiting for a good solution," said Marano. "Currently only about 1% to 2% of sufferers actually obtain treatment, in large part due to the cost, and the unacceptable nature and trauma of existing treatments - which include surgery and laser destruction of tissue."

With seed funding in place, the company is currently seeking strategic partners to share risk and accelerate product development.

Refreshments and networking will follow the seminar from 5 to 7 p.m. Registration is free, but advanced registration is required. To RSVP, send an e-mail to biohaven@yale.edu. A flyer about all events in the series is on line at http://curenet.org/download/biohaven.pdf . Directions to the event are available online at http://info.med.yale.edu/maps/cab.html.

Yale BioHaven Entrepreneurship Seminars are sponsored by the Yale Office of Cooperative Research, Connecticut United for Research Excellence (CURE), Wiggin and Dana, LLP, Elm Street Ventures, and Price Waterhouse Coopers, PC. with support from Yale Entrepreneurial Society and Yale Biotechnology & Pharmaceutical Society. For further information on the seminar, please contact Tracy Huang at tracy.huang@yale.edu .

http://www.yale.edu